New molecule reverses Alzheimer's-like memory decline

(Salk Institute) A drug candidate developed by Salk researchers, and previously shown to slow aging in brain cells, successfully reversed memory loss in a mouse model of inherited Alzheimer's disease. The new research, published online in July 2020 in the journal Redox Biology, also revealed that the drug, CMS121, works by changing how brain cells metabolize fatty molecules known as lipids.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news